Search research articles
Contact Us
Filters
Showing results (161-170 of 522) with videos related to
Page
of 53
Sort By:
International Immunopharmacology
|
February 3, 2005
LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model
Magna S Alexandre-Moreira, Christina M Takiya, Luciana B de Arruda, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
January 10, 2006
Impact of donor lung organisms on post-lung transplant pneumonia
Pramod N Bonde, Nishant D Patel, Marvin C Borja, et al.
Journal of Mass Spectrometry : JMS
|
May 14, 2005
Electrospray ionization mass and tandem mass spectra of a series of N-pyrazolylmethyl and N-triazolylmethyl N-phenylpiperazines: new dopaminergic ligands with potential antipsychotic properties
Leonardo S Santos, Monica Costa Padilha, Francisco Radler de Aquino Neto, et al.
ACS Omega
|
November 7, 2022
Methyl Effect on the Metabolism, Chemical Stability, and Permeability Profile of Bioactive <i>N</i>-Sulfonylhydrazones
Jéssica de Siqueira Guedes, Teiliane Rodrigues Carneiro, Pedro de Sena Murteira Pinheiro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 17, 2001
A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle
H Gonzalez-Serratos, R Chang, E F Pereira, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2010
Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581
Francine Pazini, Ricardo Menegatti, José R Sabino, et al.
European Journal of Medicinal Chemistry
|
November 26, 2013
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
Maria Letícia de Castro Barbosa, Lídia Moreira Lima, Roberta Tesch, et al.
American Journal of Hypertension
|
December 5, 2009
Pharmacological characterization of (3-thienylidene)-3,4-methylenedioxybenzoylhydrazide: a novel muscarinic agonist with antihypertensive profile
Gisele Zapata-Sudo, Sharlene L Pereira, Hellen J V Beiral, et al.
Plos One
|
April 21, 2018
Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats
Allan K Alencar, Fábio I Carvalho, Ananssa M Silva, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 8, 2009
Microwave-assisted synthesis and structure-activity relationships of neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives
Nailton M Nascimento-Júnior, Thaiana C F Mendes, Daniella M Leal, et al.
Page
of 53
Search research articles
Search
Showing results (161-170 of 522) with videos related to
Sort By:
Page
of 53
International Immunopharmacology
|
February 3, 2005
LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model
Magna S Alexandre-Moreira, Christina M Takiya, Luciana B de Arruda, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
January 10, 2006
Impact of donor lung organisms on post-lung transplant pneumonia
Pramod N Bonde, Nishant D Patel, Marvin C Borja, et al.
Journal of Mass Spectrometry : JMS
|
May 14, 2005
Electrospray ionization mass and tandem mass spectra of a series of N-pyrazolylmethyl and N-triazolylmethyl N-phenylpiperazines: new dopaminergic ligands with potential antipsychotic properties
Leonardo S Santos, Monica Costa Padilha, Francisco Radler de Aquino Neto, et al.
ACS Omega
|
November 7, 2022
Methyl Effect on the Metabolism, Chemical Stability, and Permeability Profile of Bioactive <i>N</i>-Sulfonylhydrazones
Jéssica de Siqueira Guedes, Teiliane Rodrigues Carneiro, Pedro de Sena Murteira Pinheiro, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 17, 2001
A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle
H Gonzalez-Serratos, R Chang, E F Pereira, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2010
Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581
Francine Pazini, Ricardo Menegatti, José R Sabino, et al.
European Journal of Medicinal Chemistry
|
November 26, 2013
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
Maria Letícia de Castro Barbosa, Lídia Moreira Lima, Roberta Tesch, et al.
American Journal of Hypertension
|
December 5, 2009
Pharmacological characterization of (3-thienylidene)-3,4-methylenedioxybenzoylhydrazide: a novel muscarinic agonist with antihypertensive profile
Gisele Zapata-Sudo, Sharlene L Pereira, Hellen J V Beiral, et al.
Plos One
|
April 21, 2018
Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats
Allan K Alencar, Fábio I Carvalho, Ananssa M Silva, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 8, 2009
Microwave-assisted synthesis and structure-activity relationships of neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives
Nailton M Nascimento-Júnior, Thaiana C F Mendes, Daniella M Leal, et al.
Page
of 53